Related Experiment Videos
Progression of multiple sclerosis is associated with exon 1 CTLA-4 gene polymorphism
M Bilińska1, I Frydecka, L Noga
1Department of Neurology, Wrocław Medical University, Poland. mbilinsk@dilnet.wroc.pl
Acta Neurologica Scandinavica
|June 8, 2004
Summary
The cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene exon 1 (A49G) polymorphism is not associated with multiple sclerosis (MS) susceptibility. However, CTLA-4 genotypes may influence MS disease progression.
Area of Science:
- Immunogenetics
- Neuroimmunology
- Genetics of Neurological Disorders
Background:
- Multiple sclerosis (MS) is a chronic central nervous system demyelinating disease with a suspected T-cell-mediated etiology.
- The cytotoxic T-lymphocyte antigen-4 (CTLA-4) molecule is crucial for regulating T-cell responses.
Purpose of the Study:
- To investigate the genetic association between the CTLA-4 gene exon 1 (A49G) polymorphism and multiple sclerosis.
- To determine if this polymorphism influences disease progression in MS patients.
Main Methods:
- Genotyping of the CTLA-4 A49G transition using polymerase chain reaction, SNaPshot kit, and capillary genetic analysis.
- Analysis of genotype, allele, and phenotype frequencies in 152 MS patients and 154 controls.
- Assessment of the association between genotypes and progression from relapsing-remitting to secondary progressive MS.
Main Results:
- No significant differences in genotype, allele, or phenotype frequencies of the CTLA-4 A49G polymorphism were observed between MS patients and controls.
- MS patients with AA and AG genotypes exhibited a 4.36-fold increased risk of progressing to secondary progressive MS compared to those with the GG genotype.
Conclusions:
- The CTLA-4 (A49G) exon 1 polymorphism is not associated with the susceptibility to multiple sclerosis.
- This specific CTLA-4 polymorphism is significantly associated with the progression of multiple sclerosis.